XOMA Royalty (XOMA) EBT Growth (5y) (2016 - 2026)
XOMA Royalty (XOMA) EBT Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.11% |
| Dec 31, 2025 | -16.54% |
| Jun 30, 2025 | -25.76% |
| Mar 31, 2025 | 18.90% |
| Dec 31, 2024 | -17.21% |
| Sep 30, 2024 | -49.33% |
| Jun 30, 2024 | -46.05% |
| Mar 31, 2024 | -39.78% |
| Dec 31, 2023 | -45.60% |
| Sep 30, 2023 | -22.42% |
| Jun 30, 2023 | -54.94% |
| Mar 31, 2023 | -23.80% |
| Dec 31, 2022 | -35.67% |
| Sep 30, 2022 | -20.33% |
| Jun 30, 2022 | -137.17% |
| Mar 31, 2022 | 27.71% |
| Dec 31, 2021 | 30.00% |
| Sep 30, 2021 | 18.75% |
| Jun 30, 2021 | 34.83% |
| Mar 31, 2021 | 13.23% |